Daniel Finney
Physician Assistant · Gold Canyon, AZNPI 1225050156
Payments from drug & device makers
Across 253 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$755
- AstraZeneca$688
- GSK$419
- Amgen$242
- Boehringer Ingelheim$203
- Exact Sciences$199
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,378100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $755 |
| AstraZeneca | 36 | $688 |
| GSK | 25 | $419 |
| Amgen | 16 | $242 |
| Boehringer Ingelheim | 11 | $203 |
| Exact Sciences | 10 | $199 |
| Novo Nordisk | 11 | $197 |
| Lilly USA, LLC | 11 | $180 |
| Pfizer | 10 | $161 |
| Abbott | 6 | $139 |
| Astellas Pharma US Inc | 6 | $127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $112 |
| Sumitomo Pharma America, Inc. | 4 | $110 |
| Dexcom, Inc. | 5 | $109 |
| Amneal Pharmaceuticals LLC | 5 | $91 |
| Ultragenyx Pharmaceutical Inc. | 4 | $84 |
| Eisai Inc. | 3 | $61 |
| Novartis | 3 | $57 |
| Viatris Specialty LLC | 2 | $54 |
| Mylan Specialty L.p. | 3 | $52 |
| Boston Scientific | 1 | $43 |
| Johnson & Johnson | 3 | $40 |
| Merck | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Medtronic | 1 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Lucid Diagnostics Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Digestive Care, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,378 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 51 | $81,192 |
| EliquisApixaban | 48 | $72,453 |
| MounjaroTirzepatide | 37 | $56,803 |
| JanuviaSitagliptin Phosphate | 22 | $33,865 |
| JardianceEmpagliflozin | 25 | $27,641 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $23,531 |
| MyrbetriqMirabegron | 16 | $18,136 |
| XareltoRivaroxaban | 14 | $12,733 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $7,133 |
| Levothyroxine Sodium | 293 | $3,263 |
| Gabapentin | 151 | $3,202 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $2,938 |
| Olmesartan Medoxomil | 89 | $2,692 |
| Atorvastatin Calcium | 364 | $2,558 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 67 | $2,509 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $197 | $81,19251 claims |
| PfizerEliquis | $161 | $72,45348 claims |
| Lilly USA, LLCMounjaro | $180 | $56,80337 claims |
| MerckJanuvia | $37 | $33,86522 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $419 | $30,66438 claims |
| Boehringer IngelheimJardiance | $203 | $27,64125 claims |
| Astellas Pharma US IncMyrbetriq | $127 | $18,13616 claims |
| Johnson & JohnsonXarelto | $40 | $12,73314 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $91 | $3,263293 claims |
| AbbVieSynthroid | $755 | $1,66217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Gold Canyon
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
- Micah LasleyPhoenix$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.